These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9535489)

  • 1. A testing system for implantable cardioverter defibrillators.
    Jenkins JM; Pelowitz DG; Jenkins RE
    J Electrocardiol; 1998; 30 Suppl():126-9. PubMed ID: 9535489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.
    Fischer A; Ousdigian KT; Johnson JW; Gillberg JM; Wilkoff BL
    Heart Rhythm; 2012 Jan; 9(1):24-31. PubMed ID: 21835150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
    Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L
    Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable Cardioverter Defibrillator Programming Characteristics, Shocked Rhythms, and Survival Among Patients Under Thirty Years of Age.
    Chang PM; Powell BD; Jones PW; Carter N; Hayes DL; Saxon LA
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1183-1190. PubMed ID: 27334356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented two-channel arrhythmia detection: an efficient diagnostic method for implantable devices.
    Chiang CM; Jenkins JM; Caswell SA; Stevenson SA; DiCarlo LA
    Pacing Clin Electrophysiol; 1996 Oct; 19(10):1493-501. PubMed ID: 8904542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator.
    Sinha AM; Stellbrink C; Schuchert A; Mox B; Jordaens L; Lamaison D; Gill J; Kaplan A; Merkely B;
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):646-52. PubMed ID: 15175058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual chamber arrhythmia detection in the implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Cardiovasc Electrophysiol; 2000 Oct; 11(10):1105-15. PubMed ID: 11059974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of third-generation implantable cardioverter defibrillators to abort shock therapy for nonsustained ventricular tachycardia due to shortcomings of the VF confirmation algorithm.
    Grimm W; Menz V; Hoffmann J; Maisch B
    Pacing Clin Electrophysiol; 1998 Apr; 21(4 Pt 1):722-7. PubMed ID: 9584303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators.
    Schmitt C; Montero M; Melichercik J
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 1):295-302. PubMed ID: 7513854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias.
    Boriani G; Wollmann C; Biffi M; Kühl M; Schuchert A; Sperzel J; Stiller S; Gasparini G; Böcker D
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):461-5. PubMed ID: 12687868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination of ventricular tachycardia from supraventricular tachycardia by a downloaded wavelet-transform morphology algorithm: a paradigm for development of implantable cardioverter defibrillator detection algorithms.
    Swerdlow CD; Brown ML; Lurie K; Zhang J; Wood NM; Olson WH; Gillberg JM
    J Cardiovasc Electrophysiol; 2002 May; 13(5):432-41. PubMed ID: 12030523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator therapy in the absence of significant symptoms. Rhythm diagnosis and management aided by stored electrogram analysis.
    Hook BG; Callans DJ; Kleiman RB; Flores BT; Marchlinski FE
    Circulation; 1993 Jun; 87(6):1897-906. PubMed ID: 8504502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified?
    Russo AM; Nayak H; Verdino R; Springman J; Gerstenfeld E; Hsia H; Marchlinski FE
    Pacing Clin Electrophysiol; 2003 Dec; 26(12):2289-95. PubMed ID: 14675014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a dual-chamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia.
    Kouakam C; Kacet S; Hazard JR; Ferraci A; Mansour H; Defaye P; Davy JM; Lambiez M;
    Europace; 2004 Jan; 6(1):32-42. PubMed ID: 14697724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced detection criteria in implantable cardioverter defibrillators: sensitivity and specificity of the stability algorithm at different heart rates.
    Kettering K; Dörnberger V; Lang R; Vonthein R; Suchalla R; Bosch RF; Mewis C; Eigenberger B; Kühlkamp V
    Pacing Clin Electrophysiol; 2001 Sep; 24(9 Pt 1):1325-33. PubMed ID: 11584454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic arrhythmia identification using analysis of the atrioventricular association. Application to a new generation of implantable defibrillators. Participating Centers of the Automatic Recognition of Arrhythmia Study Group.
    Nair M; Saoudi N; Kroiss D; Letac B
    Circulation; 1997 Feb; 95(4):967-73. PubMed ID: 9054759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.